Physician profile
Murillo Adrados
NPI 1124409453
$7,908.49
in general payments reported to CMS, 2019-2025
8 companies · $1,445 in 2025
The $1,445 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $332 · 2021: $627 · 2022: $975 · 2023: $265 · 2024: $4,265 · 2025: $1,445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,750 · Consulting Fee: $1,628 · Food and Beverage: $1,598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,749.66 |
| Consulting Fee | $1,627.50 |
| Food and Beverage | $1,597.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $2,283.76 | 2021-2024 | Reclaim |
| Depuy Synthes Sales INC. | $1,964.76 | 2021-2025 | Attune, Actis, Velys |
| Zimmer Biomet Holdings, INC. | $1,669.37 | 2022-2025 | Persona, G7, Juggerknotless Soft Anchor |
| Medacta USA, INC. | $807.84 | 2020-2025 | Gmk Sphere |
| Depuy Synthes Products, INC. | $697.50 | 2024 | |
| Stryker Corporation | $320.68 | 2020-2021 | |
| Smith+Nephew, INC. | $85.01 | 2020-2021 | |
| Heron Therapeutics, INC. | $79.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Murillo Adrados listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.